|
|
Volumn 362, Issue 9395, 2003, Pages 1581-1583
|
|
Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery [1] (multiple letters)
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTITHROMBOCYTIC AGENT;
ENOXAPARIN;
FONDAPARINUX;
HEPARIN;
FIBRINOLYTIC AGENT;
POLYSACCHARIDE;
CARDIOVASCULAR RISK;
CLINICAL FEATURE;
CLINICAL TRIAL;
DEEP VEIN THROMBOSIS;
DRUG MARKETING;
DRUG SURVEILLANCE PROGRAM;
HEALTH CARE POLICY;
HEALTH CARE SYSTEM;
HEMATOMA;
HUMAN;
LEG PAIN;
LEG SWELLING;
LETTER;
LUNG EMBOLISM;
ORTHOPEDIC SURGERY;
PHLEBOGRAPHY;
POSTOPERATIVE THROMBOSIS;
PRESCRIPTION;
PRIORITY JOURNAL;
SIDE EFFECT;
THROMBOSIS PREVENTION;
TOTAL HIP PROSTHESIS;
METHODOLOGY;
NOTE;
POSTOPERATIVE COMPLICATION;
STANDARD;
THROMBOEMBOLISM;
TREATMENT OUTCOME;
VEIN THROMBOSIS;
DRUG APPROVAL;
DRUG INDUSTRY;
ETHICS;
FINANCIAL MANAGEMENT;
FIBRINOLYTIC AGENTS;
HUMANS;
ORTHOPEDIC PROCEDURES;
POLYSACCHARIDES;
POSTOPERATIVE COMPLICATIONS;
RESEARCH DESIGN;
THROMBOEMBOLISM;
TREATMENT OUTCOME;
VENOUS THROMBOSIS;
CLINICAL TRIALS;
DRUG APPROVAL;
DRUG INDUSTRY;
FINANCING, ORGANIZED;
RESEARCH SUPPORT;
|
|
EID: 19244379694
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(03)14750-2 Document Type: Letter |
|
Times cited : (4)
|
|
References (2)
|
